Hypermethylator Phenotype and Ectopic GIP Receptor in GNAS Mutation-Negative Somatotropinomas
Mirella Hage(Université de Versailles Saint-Quentin-en-Yvelines), Peter Kamenický(Inserm), Philippe Chanson(Bicêtre Hospital), Jérôme Bouligand(Assistance Publique – Hôpitaux de Paris), Chiara Villa(Centre National de la Recherche Scientifique), Lucie Tosca(Inserm), Gérard Tachdjian, Marc Lombès(Université Paris-Sud), Éric Letouzé(Centre National de la Recherche Scientifique), Ronan Chaligné(Memorial Sloan Kettering Cancer Center), S. Gaillard(Hôpital Foch), Say Viengchareun, Alexandra Rouquette(Assistance Publique – Hôpitaux de Paris), Sylvie Salenave(Université Paris-Sud), Fabrice Parker, André Lacroix(Centre Hospitalier de l’Université de Montréal)
Cited by 40
Related Papers
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
|New England Journal of Medicine|2012|863
SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma
|Cancer Cell|2013|772
Guidelines for Acromegaly Management: An Update
|The Journal of Clinical Endocrinology & Metabolism|2009|763
Acromegaly
|Nature Reviews Disease Primers|2019|387
Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line<i>AIP</i>Mutations and Pituitary Adenomas: An International Collaborative Study
|The Journal of Clinical Endocrinology & Metabolism|2010|374